Priya Sachdeva

Stock Analyst at UBS

(2.59)

# 2,108

Out of 5,129 analysts

6

Total ratings

83.33%

Success rate

20.32%

Average return

Main Sectors:

Top Industries:

Medical Devices

Stocks Rated by Priya Sachdeva

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	NPCE NeuroPace	Maintains: Buy	$18 → $22	$14.54	+51.31%	2	Dec 16, 2025
	PEN Penumbra	Maintains: Buy	$330 → $335	$338.26	-0.96%	4	Jul 30, 2025

NeuroPace

Dec 16, 2025

Maintains: Buy

Price Target: $18 → $22

Current: $14.54

Upside: +51.31%

Penumbra

Jul 30, 2025

Maintains: Buy

Price Target: $330 → $335

Current: $338.26

Upside: -0.96%